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Abstract: The differential contribution of monocyte subsets expressing the C-C chemokine receptor 2
(CCR2) to subclinical atherosclerosis in girls and boys is unclear. In this pilot study, we compared
classical, intermediate, and nonclassical monocyte subsets expressing CCR2 in 33 obese children
of both sexes aged 8 to 16 divided by carotid intima-media thickness (IMT), considering values
above the 75th percentile (p75) as abnormally high IMT. Obesity was defined as body mass index
above the 95th percentile according to age and sex. Flow cytometry analyses revealed that boys but
not girls with IMT ≥ p75 displayed increased CCR2+ cell percentage and CCR2 expression in the
three monocyte subsets, compared to boys with IMT < p75. The CCR2+ cell percentage and CCR2
expression in the three monocyte subsets significantly correlated with increased IMT and insulin
resistance in boys but not girls, where the CCR2+ nonclassical monocyte percentage had the strongest
associations (r = 0.73 and r = 0.72, respectively). The role of CCR2+ monocyte subpopulations in
identifying an abnormally high IMT shows a marked sexual dimorphism, where boys seem to be at
higher subclinical atherosclerosis risk than girls.
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1. Introduction
Obesity is a risk factor for coronary heart disease. Cardiovascular diseases cause nearly
70% of deaths among persons with a high body mass index (BMI) [1]. Coronary artery
disease, also known as atherosclerosis, is the most common heart disease characterized by
the accumulation of cholesterol esters-ingesting macrophages in the subendothelial space
of coronary arteries [2].
During obesity, cholesterol levels considerably increase and adhere to the vascular
endothelium, triggering the local release of reactive oxygen species and the recruitment of
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macrophages, which can expand vascular injury and promote atherogenesis [3,4]. Therefore,
the atherosclerotic process originates with endothelial damage and dysfunction that lead
to the recruitment of circulating monocytes with the ability to adhere to and infiltrate the
injured arterial wall [5]. There, monocytes differentiate into macrophages that actively
uptake cholesterol esters by phagocytosis, resulting in foam cell formation and further
vessel wall inflammation. Foam cells contribute to intima-media thickening (IMT), a
condition correlating with increased insulin resistance in children with obesity who can
become individuals with advanced atherosclerosis in adult life [6–9]. In fact, insulin
resistance that reflects the progressive loss of the action of insulin on target tissues is also
an independent risk factor for developing systemic inflammation that often accompanies
atherosclerotic cardiovascular disease [10].
Monocytes are divided into three subpopulations according to CD14 and CD16
expression as follows: classical monocytes (CD14++ CD16− ), intermediate monocytes
(CD14++ CD16+ ), and nonclassical monocytes (CD14+ CD16+ ). The infiltration of monocyte
subsets into artery vessels occurs in response to the C-C chemokine receptor 2 (CCR2), a
G protein-coupled receptor whose ligands include the monocyte chemoattractant protein
(MCP) family [11].
A recent study reported an increase in intermediate monocytes expressing CCR2 in
adults with atherosclerosis [11]. CCR2 expression also elicits the adhesion of classical and
nonclassical monocytes to the vascular endothelium during atherosclerosis [12]. Another
study showed that these monocyte subsets could even help predict an impaired endothelial
dysfunction in patients with atherosclerosis in a sex- and age-dependent fashion [13].
Currently, there is evidence of the influence of sex in the risk of developing atherosclerosis. Premenopausal women display less pro-atherogenic lipid profiles than men [14].
Ischemic cardiovascular disease resulting from atherosclerosis occurs more often in men
than women. At an early age, male children and adolescents show higher IMT than
girls [15]. Sexual dimorphism also influences the CCR2–MCP-1 axis. Petty and colleagues
found that African American male adolescents present higher MCP-1 serum levels than
females [16], confirming further evidence, indicating that MCP-1 is elevated only in male
mice fed a high-fat diet (HFD) [17]. Verweij and coworkers expanded this body of evidence
by showing that being a man significantly contributes to an elevated CCR2 expression in
circulating monocytes, mostly classical monocytes [18].
Although increasing evidence in adults indicates that monocyte subsets expressing
CCR2 contribute to atherosclerosis in a sex-dependent fashion, there is still scant information on girls and boys with obesity. Herein, we conducted a pilot study to analyze CCR2+
monocyte subpopulations in children of both sexes with obesity, examining the association
of these immune cells with cardiovascular risk factors, such as IMT and insulin resistance
in a sex-dependent fashion.
2. Materials and Methods
2.1. Participants
Initially, 40 children fulfilled the inclusion criteria. After the first biochemical analysis,
we identified three volunteers with abnormally high blood cholesterol levels and removed
them from the study. Another four volunteers did not agree to provide 6 mL of venous
blood, and we withdrew them from the study. In the end, we enrolled 33 children with
obesity aged 8 to 16 years in this pilot study. We included all study participants from
the Childhood Obesity Clinic at the General Hospital of Mexico between 2017 and 2019.
All volunteers agreed to participate in the study by signing the informed consent and
assent letters. We excluded from the study participants with a diagnosis of familial hypercholesterolemia, hypertriglyceridemia, or diabetes mellitus, as well as children consuming
alcohol or any drug interfering with metabolism and immune response to avoid potential
confounding effects on parameters of subclinical atherosclerosis and CCR2 expression in
monocyte subpopulations.
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We conducted this study after getting approval from the Research, Ethics, and Biosafety
Committees for Human Research of the General Hospital of Mexico (registration number:
DI/17/311/03/028), following the ethical guidelines of the 1975 Declaration of Helsinki
and its posterior amendment in 2013. According to the clinical practice guidelines of the
Pediatric Endocrine Society, we used BMI ≥ 95th percentile according to age and sex to
diagnose obesity in the studied children [19,20]. We calculated BMI by dividing weight in
kilograms by the square of the height in meters.
2.2. Anthropometric Measurements
A group of two trained pediatricians and a nutritionist performed all anthropometric
measurements in the study population. We measured body weight and composition
using the Body Composition Analyzer Model IOI 353 scale (to 0.1 kg). Moreover, we
used a stadiometer board mounted on the wall to register height (to the nearest 0.1 cm).
We measured waist circumference (WC) using tape in a horizontal line at the midpoint
between the lowest rib and the iliac crest. We registered blood pressure with a digital
sphygmomanometer, following a fifteen-minute rest. We assessed pubertal development
according to the Tanner stages.
2.3. Biochemical Markers
We obtained blood samples after 12 h fasting to measure metabolic markers, including
glucose, insulin, uric acid, triglycerides, and liver function tests. We measured glucose,
aminotransferases, total cholesterol, high density lipoprotein (HDL) cholesterol, low density
lipoprotein (LDL) cholesterol, and triglycerides by enzymatic assays, using the Beckman
Coulter DxC 700 AU Chemistry Analyzer (Beckman Coulter Inc., Brea, CA, USA). We
determined serum insulin by ELISA (Abnova, Corporation, Taipei City, Taiwan).
We calculated the Homeostasis Model Assessment of insulin resistance (HOMA)
by multiplying fasting glucose (mg/dL) by fasting insulin (mU/L) divided by 405. We
considered children with insulin resistance as having HOMA values ≥ 3.4 [21,22].
2.4. Ultrasound Measurements
We used the Siemens Accuson 2000 ultrasound with high resolution (2 and 12 MHz)
to get all ultrasound images. We measured abdominal fat by calculating the preperitoneal
fat area (PFA). We placed a linear probe perpendicular to the skin of the median upper
abdomen, moving the probe longitudinally from the xiphoid process to the umbilicus along
with the midline to obtain an image that contained the maximum preperitoneal fat thickness.
We considered the PFA as the full height of the triangular-shaped area in the transversal
image. We measured the total preperitoneal area starting from the position of the maximum
preperitoneal thickness over a distance of 20 mm in the caudal direction [23]. We evaluated
the vascular structure as the intima-media thickness (IMT). We measured IMT in a supine
position, with the neck extended and the probe in the anterolateral place in a longitudinal
plane on the far wall of the left internal carotid artery 1 cm from the carotid bulb. A senior
expert radiologist performed five measurements on each study volunteer, using the average
IMT value for further analyses. We evaluated the inter-observer variability by calculating
Cohen’s kappa index, finding a κ = 0.89, which suggests a high reproducibility when
measuring IMT. Depending on age and sex, we defined a high-risk IMT value when it fell
above the 75th percentile (p75), based on Böhm et al. [15].
2.5. Total Leukocyte Isolation and Flow Cytometry
We obtained 6 mL of venous blood from all study participants and placed them in
vacutainer tubes treated with EDTA. Immediately after, we centrifuged blood samples
at 1200 rpm for 10 min and took the layer of white blood cells to transfer it to 2.5 mL
Eppendorf tubes. We removed red blood cells using 1 mL ACK erythrocyte lysis buffer for
7 min at 4 ◦ C. After centrifuging at 2000 rpm/4 ◦ C for 5 min, we discarded the supernatant
and obtained the leukocyte fraction. Later, we rinsed the cells with phosphate buffer saline
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1X (PBS 1X), and after a centrifugation step at 2000 rpm/4 ◦ C for 5 min, we transferred
the cell pellet to 0.6 mL Eppendorf tubes. We counted cells using a Neubauer chamber
by the Trypan blue exclusion test to determine the number of viable cells [20]. Next, we
transferred leukocytes to an additional 0.6 mL Eppendorf tube at a density of 2 × 106 cells
to incubate them with anti-CD14-PECy7 (BD Biosciences, Franklin Lakes, NJ, USA), antiCD16-PECy5 (BD Biosciences, Franklin Lakes, NJ, USA), and anti-CCR2-Alexa Fluor 647
(BioLegend, San Diego, CA, USA) for 20 min at 4 ◦ C in the absence of light. Then, we rinsed
leukocytes with PBS1X and centrifuged samples at 2000 rpm/4 ◦ C for 5 min. After that, we
discarded the supernatant and suspended the cell pallet in 200 µL PBS. We acquired cells
using the BD FACS Canto II, acquiring 10,000 monocyte events in triplicate. We categorized
monocyte subsets according to CD14 and CD16 expression: CD14++ CD16− , classical
monocytes; CD14++ CD16+ , intermediate monocytes; CD14+ CD16+ , nonclassical monocytes
(Figure 1). Whereas the percentage of positive cells reflects the number of cells expressing
the target molecule, the mean fluorescence intensity (MFI) indicates how much the target
molecule is produced in a specific cell population. For this reason, we obtained the MFI for
CCR2, considering positive and negative cell populations for this marker. We obtained the
percentage of positive cells for CCR2 using proper fluorescence minus one (FMO) controls,
using UltraComp eBeads™ (Invitrogen™, Carlsbad, CA, USA) as compensation controls.
We
performed flow cytometry assays in the same controlled-temperature cell culture
room
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between 9 and 11 in the morning to avoid procedural variations. We analyzed monocyte
subpopulations using the FlowJo software version 10.0.
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classical monocytes, CD14 CD16 cells as intermediate monocytes, and CD14 CD16 cells as nonclassical monocytes (Figure 1). We obtained the median fluorescence intensity (MFI) for CCR2 by
considering both positive and negative cell populations. We got the CCR2+ cell percentage using
fluorescence minus one (FMO) control. For each fluorochrome, we used compensation controls
through UltraComp eBeadsTM (InvitrogenTM, Carlsbad, CA, USA). We analyzed data by the FlowJo
10.0.7 software (TreeStar, Inc., Ashland, OR, USA).
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classical monocytes, CD14++ CD16+ cells as intermediate monocytes, and CD14+ CD16+ cells as
nonclassical monocytes (Figure 1). We obtained the median fluorescence intensity (MFI) for CCR2 by
considering both positive and negative cell populations. We got the CCR2+ cell percentage using
fluorescence minus one (FMO) control. For each fluorochrome, we used compensation controls
through UltraComp eBeadsTM (InvitrogenTM , Carlsbad, CA, USA). We analyzed data by the FlowJo
10.0.7 software (TreeStar, Inc., Ashland, OR, USA).

2.6. Statistics
We show data as mean ± standard deviation (SD). According to IMT stratification,
nine obese girls showed an IMT value above the p75, whereas IMT fell above the p75
in seven obese boys. We used the unpaired student T-test to compare demographic,
cardiometabolic, and immune variables between girls and boys with and without increased
IMT. We used the Pearson correlation test to calculate correlation coefficients with 95%
confidence intervals between monocyte subsets and cardiometabolic outcomes. We used
the rank-based inverse-normal transformation to estimate the interaction levels in the
regression for sex, considering age and other metabolic and cellular variables. We adjusted
data by sex, age, and sex–age interaction in multiple regression analysis, considering a
minimum of ten subjects per variable to estimate regression coefficients, standard errors,
and confidence intervals. Kappa calculation for IMT measurements was used to evaluate
reproducibility of the data. We considered a p value < 0.05 as significant. We analyzed data
using SPSS version 22.0 and the GraphPad Prism 6.01 software (GraphPad Software, La
Jolla, CA 92037, USA).
3. Results
3.1. Participants Characteristics
We enrolled 33 children with obesity with an average age of 10.9 ± 2.1, where 57.5%
were females. According to sex, we found differences in body composition, where females showed a significant 4.6% increase in body fat percentage (BFP), compared to males
(p = 0.008). Conversely, males presented 33.4% more visceral fat adiposity (VFA), compared
to females (p = 0.002) (Table 1). There were no differences between females and males for
BMI, WC, blood pressure, and PFA (Table 1). Children of both sexes presented similar
pubertal stages and glucose homeostasis, showing similar blood glucose values, glycosylated hemoglobin, insulin, and HOMA (Table 1). Furthermore, there were no differences
between females and males for uric acid, lipid profile, and liver function tests (Table 1).
Children of both sexes also displayed similar IMT values, even after adjusting data by sex,
age, or the interaction between these two variables (adjusted R square = 0.252).
Table 1. Demographic, anthropometric, biochemical, and cardiovascular characteristics of the study
participants.
All Participants
(n = 33)
Age (years)
Weight (kg)
Height (cm)
BMI (kg/m2 )
Waist (cm)
SBP(mmHg)
DBP (mmHg)
BFP (%)
VFA (cm3 )
PFA (cm2 )

Girls a
(n = 19)

Anthropometric variables
10.9 ± 2.1
11.0 ± 2.4
59.1 ± 15.1
57.8 ± 14.9
147.6 ± 10.8
145.5 ± 11.32
26.6 ± 3.3
26.8 ± 2.9
86.5 ± 10.3
84.2 ± 8.3
103.3 ± 9.8
101.5 ± 9.7
68.7 ± 8.7
66.6 ± 7.0
31.4 ± 5.0
33.3 ± 3.8
86.5 ± 34.5
71.3 ± 22.9
4.6 ± 1.6
4.5 ± 1.9

Boys b
(n = 14)

p a vs. b

10.7 ± 1.7
60.9 ± 15.8
150.4 ± 9.8
26.4 ± 3.8
89.7 ± 12.2
105.6 ± 9.8
71.5 ± 10.1
28.7 ± 5.4
107.1 ± 37.5
4.6 ± 1.1

0.741
0.559
0.210
0.786
0.134
0.247
0.118
0.008
0.002
0.860
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Table 1. Cont.
All Participants
(n = 33)

Girls a
(n = 19)

Boys b
(n = 14)

p a vs. b

Puberty Stages
Tanner Stage
1
2
3
4
5
Glucose (mg/dL)
HbA1c
Insulin (mg/dL)
HOMA
Uric acid (mg/dL)
TG (mg/dL)
ALT (UI/L)
AST (UI/L)
GGT (UI/L)
Tot Chol (mg/dL)
HDL (mg/dL)
LDL (mg/dL)
LDL/HDL Ratio
IMT (mm)

43.3%
20%
10%
23.3%
3.3%

33.3%

16.7%
5.6%
38.9%
5.6%
Glucose Homeostasis
88.6 ± 8.4
88.9 ± 8.7
5.3 ± 0.2
5.2 ± 0.1
16.4 ± 1.4
16.9 ± 7.2
3.7 ± 1.9
4.0 ± 1.7
Biochemical variables
5.7 ± 1.0
5.8 ± 1.0
138.5 ± 54.5
133.4 ± 45.3
24.8 ± 1.8
22.8 ± 8.5
28.1 ± 7.2
26.3 ± 6.8
16.2 ± 0.9
14.9 ± 3.7
Cardiovascular variables
163.7 ± 21.0
162.0 ± 18.6
40.0 ± 7.8
40.0 ± 8.0
107.2 ± 17.9
107.0 ± 16.5
2.7 ± 0.1
2.7 ± 0.6
0.56 ± 0.1
0.58 ± 0.10

58.3%
25%
26.7%
0%
0%

0.111

86.8 ± 8.2
5.3 ± 0.2
15.6 ± 10.2
3.4 ± 2.3

0.493
0.183
0.687
0.403

5.6 ± 1.1
145.4 ± 66.3
27.5 ± 13.3
30.5 ± 6.8
18.0 ± 6.5

0.958
0.567
0.235
0.105
0.134

166.0 ± 24.5
39.9 ± 7.8
107.5 ± 20.3
2.7 ± 0.7
0.55 ± 0.11

0.603
0.965
0.938
0.924
0.399

Values are expressed as mean (standard deviation) for normal distribution. T-test analysis, Bold data are p
values < 0.05. BMI: body mass index, SDB: systolic blood pressure, DPB: diastolic blood pressure, Tot Chol:
total cholesterol, HbA1c: glycated hemoglobin, HOMA: homeostasis model assessment, HDL: high density
lipoprotein cholesterol, LDL: low density lipoprotein cholesterol, TG: triglycerides, ALT: alanine aminotransferase,
AST: aspartate aminotransferase, GGT: gamma glutamyl transferase, BFP: body fat percentage, VFA: visceral fat
adiposity, PFA: preperitoneal fat area, IMT: intima media thickness. “a ” and “b ” are placed to represent girls and
boys and identify that the p value is the result of the comparison of both.

3.2. CCR2+ Monocyte Subsets in Boys and Girls with Obesity and High Risk IMT
Among all study participants, seven boys and nine girls showed IMT values above
the p75. We found an overall increase in both CCR2+ monocyte percentage (37.3 ± 17.4%,
p = 0.017) and CCR2 expression (20.2 ± 4.3%, p = 0.017) in male obese children, compared
to females. The CCR2+ classical monocyte percentage was 14.7 ± 9.47% higher in male
obese children with subclinical atherosclerosis risk than in boys with IMT < p75 (p = 0.039).
Moreover, CCR2 expression in this monocyte subset was 20.3% ± 1.02% higher in male
obese children with IMT ≥ p75 than in boys with IMT values below the p75 (p = 0.029)
(Figure 2).
The intermediate monocyte subpopulation displayed similar behavior, where the
CCR2+ cell percentage was 50 ± 36.7% higher in male children with IMT ≥ p75 than in
boys with IMT below the p75 (p = 0.044). The CCR2 expression was 16.1% ± 6.5% higher
in intermediate monocytes from boys with IMT ≥ p75 than in male children without
subclinical atherosclerosis risk (p = 0.047) (Figure 3).
The proportion of nonclassical monocyte expressing CCR2 was 92.3± 80.1% higher in
male children with IMT ≥ p75 than in those without a high-risk IMT (p = 0.037) (Figure 4).
Moreover, the CCR2 MFI was 23.1 ± 8.4% higher in nonclassical monocytes from male
children with high cardiovascular risk than in males with normal IMT (p = 0.020) (Figure 4).
We found no differences in obese girls with IMT below the p75.
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Table 2. Correlation of monocyte subsets expressing CCR2 with IMT and HOMA in boys and girls
with obesity.
CCR2 %

CCR2 MFI

IMT ≥ p75

HOMA ≥ 3.4

IMT ≥ p75

HOMA ≥ 3.4

CM

Boys (n = 14)
Girls (n = 19)

r = 0.56 * (0.07–0.85)
r = −0.05 (−0.68–0.58)

r = 0.21 (−0.45–0.72)
r = −0.11 (−0.72–0.60)

r = 0.61 * (0.20–0.86)
r = 0.22 (−0.36–0.72)

r = 0.22 (−0.45–0.70)
r = −0.21 (−0.88–0.42)

IM

Boys (n = 14)
Girls (n = 19)

r = 0.62 * (0.17–0.88)
r = 0.27 (−0.27–0.88)

r = 0.41 (−0.12–0.88)
r = 0.03 (−0.62–0.80)

r = 0.62 * (0.19–0.91)
r = −0.04 (−0.60–0.48)

r = 0.52 (−0.00–0.86)
r = −0.07 (−0.68–0.50)
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Table 2. Cont.
CCR2 %

NCM

Boys (n = 14)
Girls (n = 19)

CCR2 MFI

IMT ≥ p75

HOMA ≥ 3.4

IMT ≥ p75

HOMA ≥ 3.4

r = 0.72 ** (0.38–0.91)
r = 0.15 (−0.39–0.74)

r = 0.80 ** (0.60–0.93)
r = −0.22 (−0.71–0.40)

r = 0.73 ** (0.45–0.91)
r = −0.21 (−0.75–0.33)

r = 0.70 ** (0.40–0.90)
r = −0.20 (−0.69–0.37)

CCR2 (%) indicates the percentage of monocytes expressing CCR2, while CCR2 (MFI) denotes how big CCR2 is
expressed in each monocyte subset. We considered children with IMT ≥ p75 to have a higher risk for subclinical
atherosclerosis. We considered HOMA ≥ 3.4 as a higher risk for insulin resistance. The number of girls we
analyzed was 19, whereas we incorporated 14 boys into the study. The table shows correlation coefficient values (r)
that we calculated by Pearson’s correlation coefficient with 95% confidence intervals written between parentheses.
We considered significant values when p < 0.05, indicating them in bold as follows: * p < 0.05, ** p < 0.001. CM,
classical monocytes; IM, intermediate monocytes; NCM, nonclassical monocytes; MFI, mean fluorescent intensity;
IMT, intima-media thickness; HOMA, homeostasis model assessment for insulin resistance.

4. Discussion
The contribution of sexual dimorphism in synergy with monocyte subpopulations
expressing CCR2 to the development of atherosclerosis, since early ages is still unclear.
Studies in animal models and human adults show that CCR2 expression in monocytes is
associated with increased arterial wall inflammation and atherosclerosis progression, where
males exhibit more robust CCR2 expression than females [15]. Herein, we used IMT ≥ p75
adjusted by sex and age as an early surrogate marker of subclinical atherosclerosis and
cardiovascular risk in children with obesity instead of using a cutoff value of IMT that
could lead us to bias and data misinterpretation [15]. In this scenario, we found that only
boys with IMT ≥ p75 showed increased CCR2 expression in classical, intermediate, and
nonclassical monocytes, compared to girls that also exhibited considerably high IMT values.
In line with our results, two independent studies previously reported that compared to
females, male adolescents display higher circulating levels of MCP-1, a CCR2 ligand whose
interaction stimulates monocyte mobilization toward damaged tissues [16,24]. Simoes and
coworkers observed that boys with obesity showed increased serum amyloid A (SAA)
values, compared to girls; SAA induces MCP-1 production in monocytes and is associated
with a higher risk of atherosclerosis [25,26]. These findings suggest that the atherosclerotic
process may begin early in childhood in a sex-dependent fashion, resulting from the interaction between obesity, monocyte activation, and intima-media progressive thickening. As
mentioned, the binding of the chemokine MCP-1 to CCR2 in circulating monocytes is one
of the earliest steps in atherogenesis and is intimately linked to IMT continuing enlargement [27,28]. Okumoto and coworkers reported that monocytes expressing CCR2 correlate
with increased IMT and are an independent risk factor promoting atherogenesis [29]. In this
study, we observed a strong positive correlation of CCR2 expression in all monocyte subsets
with IMT in male children but not in girls. Notably, nonclassical monocytes from boys
with elevated IMT exhibited the highest increment in CCR2 expression, compared to male
children with average IMT values and girls with and without IMT ≥ p75. Nonclassical and
classical monocytes are recruited to vascular fatty streaks to form the atherosclerotic plaque,
where classical monocytes migrate into the vascular wall, and nonclassical monocyte subsets remain in the lumen exerting patrolling functions [30]. It is feasible that the increase in
nonclassical monocytes expressing CCR2 may reflect an attempt of these immune cells to
repair the injured vascular endothelium, a notion suggesting the use of these cells as an
early marker of subclinical atherosclerosis in obese boys.
The sexual dimorphism we saw in this work is supported by other studies in adults
where monocyte subsets are linked to increased IMT in a sex-dependent fashion. Cannon
and coworkers observed a positive correlation between IMT and nonclassical monocytes,
where men showed a higher nonclassical monocyte percentage than women [31]. Feinstein
and coworkers recently reported in male adults but not females that nonclassical monocytes
correlate with IMT expansion during a ten-year follow-up [32]. Rogacev and coworkers
found a higher classical monocyte percentage in male patients subjected to coronary angiography than in women facing the same procedure [33]. Altogether, this information
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expands the knowledge behind the increased risk of developing atherosclerosis in males
with obesity, compared to overweighed females, where monocyte subsets dynamically contribute to plaque formation. Studies in adult subjects found that classical and intermediate
monocytes could predict adverse cardiovascular events [33,34]. Feinstein and coworkers
reported that nonclassical monocytes could be an early biomarker of pre-atherosclerotic
vascular lesion formation [32]. Larger studies in children are needed to evaluate the use of
circulating monocyte subpopulations as accurate predictors of subclinical atherosclerosis.
Insulin resistance is defined as a reduce response of insulin-target tissues, such as the
liver, skeletal muscle, and visceral fat to insulin action [35]. Insulin resistance leads to persistent hyperglycemia and is a risk factor intimately linked to atherosclerosis development.
In an insulin-resistant setting, a reduced nitrite oxide (NO) bioavailability induces vascular
damage, increasing the expression of adhesion molecules and inflammatory cytokines with
the ability to promote monocyte recruitment and infiltration to the blood vessel wall [36].
It was our rationale behind estimating insulin resistance in our cohort of obese children,
analyzing potential associations of monocyte subsets, expressing CCR2 with IMT and
insulin resistance. Other studies in adult individuals looked for similar correlations between circulating monocytes and markers of altered glucose homeostasis associated with
atherosclerosis progression. Poitou and coworkers observed that nonclassical monocytes
were independently associated with fasting glycemia [37]. Mine and coworkers found
increased CCR2 expression in circulating monocytes from diabetic patients, compared
to control subjects, informing a direct correlation of CCL2 serum levels with glycated
hemoglobin (HgA1c) [38]. Gallego-Suárez and coworkers reported a positive correlation of
classical monocytes with HOMA in children with high BMI [39]. In line with these findings,
we found a strong positive correlation of CCR2 expression in nonclassical monocytes with
insulin resistance only in male children with IMT > p75. We encourage other research
teams to assess whether the interaction between monocyte subsets expressing CCR2 and
insulin resistance, as surrogate markers of subclinical atherosclerosis, can help understand
the development of subclinical atherosclerosis early in life. Recently, research in this field is
gaining attention because of novel therapeutic approach that blocks the CCL2–CCR2 axis
and may improve atherosclerosis disease [40].
Due to the increasing obesity rates, cardiovascular events are still the leading cause
of mortality worldwide, above all in men. Ischemic cardiovascular disease caused by
atherosclerosis is more prevalent and often occurs earlier in men than in women [14].
Cardiovascular diseases are linked to insulin resistance and T2D, which are more prevalent
in males than females [41]. Our findings in obese boys with IMT above average values indicate
that sexual dimorphism can appear early in life. Sex differences in body composition exist
even before exposure to gonadal hormones [42]. Males cumulate more visceral adipose tissue
(VAT), whereas females amass more subcutaneous adipose tissue (SAT) [43]. Numerous lines
of research have consistently reported that VAT gain triggers low-grade inflammation and
monocyte activation, increasing the risk of developing insulin resistance, T2D, atherosclerosis,
and ischemic heart disease [44]. In line with these findings, we observed that male children
with obesity had more VAT than females, which could partially explain the increase in CCR2
expression in circulating monocytes from boys with IMT > p75.
This pilot study has some limitations. First, although statistically acceptable, the
sample size appears small to estimate whether potentially confounding variables, such
as sex or sexual development, may impact the measurement of intima-media thickness.
To lessen the effect of this limitation, we adjusted data by age, sex, and the interaction of
sex with age in multiple regression models, finding that only age but not sex appears to
influence IMT. Another limitation of the study is that we analyzed body composition using
a Body Composition Analyzer Model IOI 353 scale suitable for examining the pediatric
population. However, if available, we would have liked to evaluate body composition
using dual-energy X-ray absorptiometry (DEXA) or magnetic resonance imaging (MRI).
Conversely, a strength of the work is that children enrolled in the study had no previous
pharmacological treatment that could influence CCR2 expression, monocyte subset dy-
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namic, or IMT values. We are now working on increasing the number of children enrolled
in the study to clarify the contribution of circulating monocytes expressing CCR2 and other
chemokine receptor repertoires to atherosclerosis development in a sex-dependent fashion.
5. Conclusions
In conclusion, CCR2 expression in circulating monocyte subsets is associated with elevated
IMT and insulin resistance in male children with obesity. Circulating monocytes expressing
CCR2, mostly nonclassical monocytes, may contribute to atherosclerotic plaque formation in a
sex-dependent fashion, where boys appear to be at increased cardiovascular risk.
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